Tue, Dec 23, 2014
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Industry Updates

Eurekahedge Hedge Fund Index up 8% in 2013, hedge funds gain $225bn+ in 2013

Thursday, January 02, 2014
Opalesque Industry Update - The Eurekahedge Hedge Fund Index was up 0.99% in December, bringing the yearly returns for 2013 to 8.02%. The MSCI World Index returned 1.67% in December and was up 21.1% for the year 2013.

Hedge funds remained in positive territory throughout the year, suffering a setback in June and August of 2013 as uncertainty loomed in the underlying markets following the Fed's 'taper scare'. Overall, hedge fund managers were up 2.53% in the first half and 5.36% in the second half of the year. Most regional mandates ended the year on a positive note, with Japan and Greater China focused hedge funds outshining the rest. Among investment strategies, distressed debt investing hedge funds were the best performers during the year, with long short equity and event driven strategies also delivering strong returns.

In terms of capital raising, North American fund managers were the most successful attracting US$73.6 billion of asset inflows during the year, followed by European and Asia ex-Japan fund managers who saw capital allocations of US$62.4 billion and US$11.0 billion in 2013.

Funds of hedge funds had their best year relative to the hedge fund industry on record.

Hedge fund highlights for 2013:

· Hedge fund returns were up for the fourth consecutive month with the Eurekahedge Hedge Fund Index gaining 0.99% in December and 8.02% overall in 2013.

· Total assets grew by US$228.8 billion – the fastest annual growth on record since 2007 with total assets under management of the hedge fund industry standing at a historic high of US$2.01 trillion.

· Hedge fund managers attracted US$146.1 billion in the form of net capital allocations during the year – an impressive turnaround given the industry saw a total of US$109.6 billion of net asset flows in the previous three years combined.

· Hedge funds focused on Asia Pacific realised the best returns and were up 15.3% in 2013 with Japan and Greater China focused hedge funds delivering the best regional results up 25.7% and 19.3% respectively.

· The Mizuho-Eurekahedge Index, an asset-weighted index, finished the year with gains of 6.63% indicating that the larger funds slightly underperformed the small and medium sized funds.

· Distressed debt hedge funds delivered the strongest performance among all strategies, gaining 16.8% in 2013, while long/short equities hedge funds were up 14.3% followed by event driven hedge funds which gained 11.3% during the year.

· The Eurekahedge Fund of Funds Index was up 7.79%, marginally behind hedge funds as multi-managers posted their best performance since 2009.

· Fund of hedge funds managers' are now tracking hedge funds more closely than ever with multi-managers outperforming underlying hedge funds in 6 out of the 12 months this year. A combination of reduced fees, increased diversification and the weeding out of underperforming fund of funds has rendered the multi-manager model more agile than ever.

Press release

Eurekahedge
www.eurekahedge.com

Bg

What do you think?

   Use "anonymous" as my name    |   Alert me via email on new comments   |   
Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Hong Kong-Shanghai stock link fails to live up to expectation so far[more]

    Komfie Manalo, Opalesque Asia: In a report, Reuters said that demand has been subdued with the bulk of activities coming from short-term speculative investors. Las

  2. Investing - Hedge funds get boost from healthcare in 2014, Paulson & Co takes stake in Salix on heels of inventory issues[more]

    Hedge funds get boost from healthcare in 2014 From Valuewalk.com: The healthcare sector started the year on a turbulent note, as stocks of many major biotechnology companies were battered. However, most of the players in this sector have bounced back. The BarclayHedge Healthcare & Biotec

  3. North America - Why Steve Cohen, Connecticut hedge fund billionaire, gives so much in New York[more]

    From Insidephilantrophy.com: Billionaire Steve Cohen was born in Great Neck, New York before attending Wharton, working on Wall Street and then founding SAC Capital Advisors in Connecticut. Though his company (Point72) and foundation are based in Connecticut, Cohen and Alexandra are deeply connected

  4. Investing - Soros buys a highly speculative biotech in the third quarter[more]

    From Fool.com: …The Soros Fund bought 25,000 shares of the struggling small-cap biopharma Aegerion Pharmaceuticals in the third quarter. For those of you who haven't heard of this name, suffice to say that this was a surprising buy in light of the company's recent problems and poor outlook going for

  5. CFTC Revokes Registrations of Illinois Resident Aleks A. Kins and Chicago-based AlphaMetrix, LLC[more]

    Matthias Knab, Opalesque: The U.S. Commodity Futures Trading Commission (CFTC) today announced that it has revoked the registration of Aleks A. Kins of Chicago, Illinois, as an Associated Person and the registrations of AlphaMetrix, LLC (AlphaMetrix), a Delaware limited liability company with its